BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 16054753)

  • 81. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Apolipoprotein E polymorphism in elderly east Africans.
    Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
    East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
    [TBL] [Abstract][Full Text] [Related]  

  • 85. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
    Zubenko GS; Hughes HB; Stiffler JS
    Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
    [TBL] [Abstract][Full Text] [Related]  

  • 86. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
    Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
    Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Association between apolipoprotein E polymorphism and Alzheimer's disease: A population-based study in Guangzhou, China].
    Lai S; Chen Y; Wen Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):202-4. PubMed ID: 11860878
    [TBL] [Abstract][Full Text] [Related]  

  • 88. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
    Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
    Saarela MS; Lehtimäki T; Rinne JO; Hervonen A; Jylhä M; Röyttä M; Ahonen JP; Mattila KM
    Neurosci Lett; 2004 Sep; 367(3):336-9. PubMed ID: 15337261
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.
    Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F
    Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
    Reynolds WF; Rhees J; Maciejewski D; Paladino T; Sieburg H; Maki RA; Masliah E
    Exp Neurol; 1999 Jan; 155(1):31-41. PubMed ID: 9918702
    [TBL] [Abstract][Full Text] [Related]  

  • 94. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
    Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
    Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
    Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease.
    Tedde A; Bagnoli S; Piaceri I; Lucenteforte E; Bessi V; Bracco L; Mugelli A; Sorbi S; Nacmias B
    Neurosci Lett; 2010 Jun; 477(3):121-3. PubMed ID: 20430066
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L; Milanese M; Arosio B; Vergani C; Crovella S
    Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease.
    Maes OC; Schipper HM; Chong G; Chertkow HM; Wang E
    Neurobiol Aging; 2010 Jan; 31(1):34-45. PubMed ID: 18423940
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
    Guidi I; Galimberti D; Venturelli E; Lovati C; Del Bo R; Fenoglio C; Gatti A; Dominici R; Galbiati S; Virgilio R; Pomati S; Comi GP; Mariani C; Forloni G; Bresolin N; Scarpini E
    Neurobiol Aging; 2005 Jun; 26(6):789-94. PubMed ID: 15718036
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Schizophrenia and apolipoprotein E gene polymorphism in Serbian population.
    Kecmanović M; Dobricić V; Dimitrijević R; Keckarević D; Savić-Pavićević D; Keckarević-Marković M; Ivkovic M; Romac S
    Int J Neurosci; 2010 Jul; 120(7):502-6. PubMed ID: 20583903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.